What is the difference between Glutathione and NAD+?

Glutathione: Glutathione is an endogenous tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) that serves as the principal intracellular antioxidant in mammalian cells. It is not FDA-approved as a drug in the US; pa... NAD+: NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in all living cells, not a peptide. It is classified here alongside peptides for user convenience in the anti-aging / metabolic category....

What does the research say about Glutathione vs NAD+?

Glutathione: A randomized, double-blind pilot trial (Hauser et al., Movement Disorders, 2009, PMID 19230029) tested IV glutathione 1,400 mg three times weekly for 4 weeks in Parkinson's disease (n=21); it was well tolerated but did NOT show a statistically significant effect on UPDRS scores. A large randomized trial of inhaled glutathione (646 mg every 12 hours… NAD+: The strongest human evidence for raising circulating NAD+ comes from oral-precursor trials. A randomized, double-blind, placebo-controlled study of nicotinamide riboside combined with pterostilbene (NRPT) showed sustained dose-dependent increases in whole-blood NAD+ over 8 weeks in healthy adults (Dellinger et al., npj Aging and Mechanisms of Disea…

Glutathione vs NAD+

Q: Can you stack Glutathione and NAD+?

Glutathione (immune) and NAD+ (metabolic) are in different categories and are sometimes researched together in combined protocols. Consult a licensed provider before combining any compounds.

Head-to-head comparison of Glutathione and NAD+ — mechanism, side effects, legal status, and pricing.

Glutathione

Glutathione is an endogenous tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) that serves as the principal intracellular antioxidant in mammalian cells. It is not FDA-approved as a drug in the US; parenteral glutathione is used off-label (and in some compounding settings) for oxidative stress, hepatic support, and — controversially — skin lightening. The FDA has warned against injectable glutathione for skin lightening (2019) due to reports of serious adverse events.

Profile Prices Testing

NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in all living cells, not a peptide. It is classified here alongside peptides for user convenience in the anti-aging / metabolic category. NAD+ plays a central role in cellular energy metabolism and redox reactions and is studied for its involvement in mitochondrial function, DNA-damage signaling via sirtuins and PARPs, and age-associated metabolic decline. IV NAD+ is not FDA-approved for any clinical indication; it is administered off-label through compounding pharmacies and functional-medicine clinics with limited rigorous outcome data.

Profile Prices Testing

Glutathione

NAD+

Category

Immune

Metabolic

Legal Status

Research Only

Mechanism

Glutathione cycles between reduced (GSH) and oxidized (GSSG) forms, donating electrons to reactive oxygen species via glutathione peroxidase. It serves as a cofactor for glutathione S-transferases (GSTs) in Phase II detoxification, maintains reduced protein thiols, supports T-cell proliferation and NK cell cytotoxicity, and regenerates vitamins C and E. Proposed skin-lightening activity is attributed to inhibition of tyrosinase and a shift from eumelanin toward phaeomelanin synthesis, though clinical evidence is limited and largely from small Asian dermatology trials.

NAD+ functions as a primary electron carrier in glycolysis, the TCA cycle, and oxidative phosphorylation. Beyond its redox role, NAD+ serves as a consumable substrate for sirtuin deacetylases (SIRT1-7), poly(ADP-ribose) polymerases (PARPs), and CD38/CD157 ectoenzymes. Sirtuin activation is linked to mitochondrial biogenesis, autophagy, and stress-response gene expression, and PARP activity is central to DNA-damage repair. Oral bioavailability of intact NAD+ is poor, which is why clinics market IV infusion; the best human data for raising tissue NAD+ involve oral precursors NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) rather than NAD+ itself.

Side Effects

Bloating and abdominal cramps (oral administration)
Zinc depletion with prolonged high-dose use
Bronchospasm (inhaled formulations)
Severe cutaneous adverse reactions — Stevens-Johnson syndrome and toxic epidermal necrolysis — reported with unregulated injectable skin-lightening use (FDA 2019)

Where Researchers Are Buying

Live · updated daily

COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower

Glutathione

Best $/mg

$0.023/mg

Peptide Supply Co.B

11 trusted vendors listing

Compare all 11 vendors

NAD+

Best $/mg

$0.040/mg

Peptide Supply Co.B

22 trusted vendors listing

Compare all 22 vendors

Lab Verification

COA corpus from Disclosed Labs — independently tested batches only.

Glutathione

COAs

99.5%

Avg purity

Labs

Full testing data

NAD+

146

COAs

99.4%

Avg purity

Labs

Full testing data

Glutathione Research Summary

A randomized, double-blind pilot trial (Hauser et al., Movement Disorders, 2009, PMID 19230029) tested IV glutathione 1,400 mg three times weekly for 4 weeks in Parkinson's disease (n=21); it was well tolerated but did NOT show a statistically significant effect on UPDRS scores. A large randomized trial of inhaled glutathione (646 mg every 12 hours for 6 months) in cystic fibrosis (Griese et al., Am J Respir Crit Care Med, 2013, PMID 23631796) did not demonstrate clinically relevant improvements in lung function, exacerbations, or quality of life. Oral glutathione has poor bioavailability due to GI degradation, driving investigation of IV, nebulized, liposomal, and sublingual delivery. The FDA issued a 2019 warning about compounded sterile injectable glutathione made from dietary-grade ingredient, citing adverse-event reports (including Stevens-Johnson syndrome, toxic epidermal necrolysis, and kidney dysfunction) particularly in the context of unregulated IV skin-lightening use.

Key references

NAD+ Research Summary

The strongest human evidence for raising circulating NAD+ comes from oral-precursor trials. A randomized, double-blind, placebo-controlled study of nicotinamide riboside combined with pterostilbene (NRPT) showed sustained dose-dependent increases in whole-blood NAD+ over 8 weeks in healthy adults (Dellinger et al., npj Aging and Mechanisms of Disease, 2017). A Yoshino/Baur/Imai review summarizes the biology and emerging therapeutic potential of NR and NMN, including preclinical healthspan data in aged mice (Cell Metabolism, 2018). Direct IV NAD+ has only small pilot pharmacokinetic data: Grant et al. infused 750 mg over 6 hours in 8 healthy men and documented altered plasma and urine NAD+ metabolome without clinical-outcome endpoints (Frontiers in Aging Neuroscience, 2019). No adequately powered RCTs support IV or SubQ NAD+ for anti-aging, cognition, addiction, or Parkinson's disease; clinic marketing claims outrun the published outcome evidence.

Can you stack Glutathione and NAD+?

Glutathione (Immune) and NAD+ (Metabolic) are in different categories and target different biological pathways. This is a common pattern in multi-compound research protocols. Researchers should monitor the biomarkers from both profiles and watch for interactions listed in each compound’s contraindications. Consult a licensed healthcare provider before combining any research compounds.

Related Research

Cheapest verified NAD+: live prices, vendors & COA data

The cheapest verified NAD+ by price-per-mg — a live board of in-stock vendors with COAs on file. Lab data from 15 labs across 158 COAs.

Browse all research

Other comparisons

NAD+ vs Selank NAD+ vs Semax Dihexa vs NAD+NAD+ vs PE-22-28 Cerebrolysin vs NAD+NAD+ vs Pinealon NAD+ vs P21 Chonluten vs NAD+

This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.